Compounds > sarpogrelate
Page last updated: 2024-11-04

sarpogrelate and Arrhythmias, Cardiac

sarpogrelate has been researched along with Arrhythmias, Cardiac in 2 studies

sarpogrelate: structure given in first source

Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barta, J2
Sanganalmath, SK2
Kumamoto, H2
Takeda, N2
Edes, I1
Dhalla, NS2

Other Studies

2 other studies available for sarpogrelate and Arrhythmias, Cardiac

ArticleYear
Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality.
    Cardiovascular toxicology, 2008,Fall, Volume: 8, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cilostazol; Coronary Occlusion; Cyclic AMP; D

2008
Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Cilostazol; Disease Models, Animal; Echocardiography; Electrocardiogr

2008